Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ben Van Baelen"'
Autor:
Ramon Roozendaal, Jenny Hendriks, Thierry van Effelterre, Bart Spiessens, Liesbeth Dekking, Laura Solforosi, Dominika Czapska-Casey, Viki Bockstal, Jeroen Stoop, Daniel Splinter, Sarah Janssen, Ben van Baelen, Nadia Verbruggen, Jan Serroyen, Eline Dekeyster, Ariane Volkmann, Yvonne Wollmann, Ricardo Carrion, Luis D. Giavedoni, Cynthia Robinson, Maarten Leyssen, Macaya Douoguih, Kerstin Luhn, Maria Grazia Pau, Jerry Sadoff, An Vandebosch, Hanneke Schuitemaker, Roland Zahn, Benoit Callendret
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
Abstract It has been proven challenging to conduct traditional efficacy trials for Ebola virus (EBOV) vaccines. In the absence of efficacy data, immunobridging is an approach to infer the likelihood of a vaccine protective effect, by translating vacc
Externí odkaz:
https://doaj.org/article/31753f8ec19c4f7ca129201ac99ccb00
Autor:
Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, Herta Crauwels, Ludo Lavreys, Lotke Tambuyzer, Ben Van Baelen, Simon Vanveggel, Magda Opsomer
Publikováno v:
SAGE Open Medicine, Vol 5 (2017)
Objective: VIOLIN (TMC125IFD3002; NCT01422330) evaluated the safety, tolerability, and pharmacokinetics of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected patients. Methods: In a 48-week, phase IV, single-arm, multice
Externí odkaz:
https://doaj.org/article/1d2fcd3a30fa484aba5a23fc61ee58a6
Autor:
John, Steytler, Charles, Craig, Elna, van der Ryst, Ben, Van Baelen, Jeremy, Nuttall, Neliëtte, van Niekerk, John, Mellors, Urvi, Parikh, Carole, Wallis
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The Ring Study, a 2:1 randomized, double-blind, placebo-controlled Phase III trial, demonstrated 35.1% HIV-1 infection risk reduction among participants using the Dapivirine Vaginal Ring-004 (DVR). An open-label extension trial, DREAM, approximated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3502af9e099b06e42c3a8da7793385ea
https://pubmed.ncbi.nlm.nih.gov/36345569
https://pubmed.ncbi.nlm.nih.gov/36345569
Autor:
John, Steytler, Elna, van der Ryst, Charles, Craig, Ben, Van Baelen, Jeremy, Nuttall, Neliëtte, van Niekerk, John, Mellors, Urvi, Parikh, Carole, Wallis
Publikováno v:
Clin Infect Dis
BACKGROUND: Participants with human immunodeficiency virus (HIV) seroconversion in The Ring Study, a phase 3 trial of dapivirine vaginal ring (DVR), or in the open-label extension trial dapivirine ring extended access and monitoring (DREAM) were offe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e0de3c7118f13b9b0913731e70238e8d
https://pubmed.ncbi.nlm.nih.gov/36189636
https://pubmed.ncbi.nlm.nih.gov/36189636
Autor:
Bart Spiessens, Ramon Roozendaal, Liesbeth Dekking, Maria Grazia Pau, Cynthia Robinson, Dominika N. Czapska-Casey, Yvonne Wollmann, Thierry Van Effelterre, Viki Bockstal, Eline Dekeyster, Roland Zahn, Jeroen N Stoop, Kerstin Luhn, Jan Serroyen, Luis D. Giavedoni, Jenny Hendriks, Sarah Janssen, Maarten Leyssen, Ben Van Baelen, Hanneke Schuitemaker, Ricardo Carrion, Daniel Splinter, An Vandebosch, Jerry Sadoff, Ariane Volkmann, Nadia Verbruggen, Macaya Douoguih, Laura Solforosi, Benoit Callendret
Publikováno v:
NPJ VACCINES
npj Vaccines
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
npj Vaccines
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
It has been proven challenging to conduct traditional efficacy trials for Ebola virus (EBOV) vaccines. In the absence of efficacy data, immunobridging is an approach to infer the likelihood of a vaccine protective effect, by translating vaccine immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a435e1265a441954725ed3930a761f9
http://hdl.handle.net/1887/3562934
http://hdl.handle.net/1887/3562934
Autor:
Alexander S, Pym, Andreas H, Diacon, Shen-Jie, Tang, Francesca, Conradie, Manfred, Danilovits, Charoen, Chuchottaworn, Irina, Vasilyeva, Koen, Andries, Nyasha, Bakare, Tine, De Marez, Myriam, Haxaire-Theeuwes, Nacer, Lounis, Paul, Meyvisch, Ben, Van Baelen, Rolf P G, van Heeswijk, Brian, Dannemann, Xia, Zhang
Publikováno v:
European Respiratory Journal. 47:564-574
Bedaquiline, a diarylquinoline, improved cure rates when added to a multidrug-resistant tuberculosis (MDR-TB) treatment regimen in a previous placebo-controlled, phase 2 trial (TMC207-C208; NCT00449644). The current phase 2, multicenter, open-label,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff1a02d794789f230b1e419e42384b2
https://doi.org/10.1183/13993003.00724-2015
https://doi.org/10.1183/13993003.00724-2015
Autor:
Marie-Pierre de Béthune, Sandra De Meyer, Ben van Baelen, Gaston Picchio, Eric Lefebvre, Tony Vangeneugden, Herwig Van Marck, Els De Paepe
Publikováno v:
AIDS Research and Human Retroviruses. 24:379-388
The resistance profile of darunavir (TMC114) in treatment-experienced patients was explored using pooled week 24 data from POWER 1, 2, and 3 at the recommended dose of darunavir with low-dose ritonavir (darunavir/r, 600/100 mg bid, N = 458). Baseline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f417fc81dc89a64fc3836b4597ef36d3
https://doi.org/10.1089/aid.2007.0173
https://doi.org/10.1089/aid.2007.0173
Autor:
Magda Opsomer, Rodica Silaghi, Ludo Lavreys, Herta Crauwels, As’ad E. Bhorat, Simon Vanveggel, Lotke Tambuyzer, Eduardo Arathoon, Ben Van Baelen
Publikováno v:
SAGE Open Medicine
SAGE Open Medicine, Vol 5 (2017)
SAGE Open Medicine, Vol 5 (2017)
Objective: VIOLIN (TMC125IFD3002; NCT01422330) evaluated the safety, tolerability, and pharmacokinetics of etravirine with antiretrovirals other than darunavir/ritonavir in HIV-1-infected patients. Methods: In a 48-week, phase IV, single-arm, multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d39f94bbee61643e75b86e2b245da07
https://doi.org/10.1177/2050312116686482
https://doi.org/10.1177/2050312116686482
Autor:
Ben van Baelen, Joshua Henshaw, Maja Mockenhaupt, Priya Singhal, Leif Bengtsson, Emily C. Martin, Robert S. Kauffman, Robert S. Stern, Steven R. Tahan, Matthew W. Harding, Jean-Claude Roujeau
Publikováno v:
JAMA dermatology. 149(2)
Objective To evaluate the incidence, type, and severity of telaprevir-associated skin reactions. Design Three dermatologists assessed available information including photographs, biopsy results, and clinical summaries of all cases with skin eruptions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f6996c3985718d6cf1391e5842128e
https://pubmed.ncbi.nlm.nih.gov/23560295
https://pubmed.ncbi.nlm.nih.gov/23560295